Key Highlights
- Microvast Holdings (NASDAQ:MVST) is down 49.17% pre-market at USD 0.3139 on Tuesday, November 10, 2026, after third-quarter Revenue fell 62.8% to USD 45.8 million and a Going Concern warning stayed in place.
- Karyopharm Therapeutics (NASDAQ:KPTI) slipped 22.25% to USD 0.0311 following its Chapter 11 filing, with Nasdaq trading suspended from November 11, 2026 and a plan that leaves common stockholders with no distribution.
- Vivakor fell 19.4% to USD 0.3057 and Flux Power (NASDAQ:FLUX) dropped 15.9% to USD 0.3035. Published coverage holds no new catalyst dated November 9 or November 10 for either.
- Parabolic Technologies (NASDAQ:PARA) slid 14.74% to USD 0.0746 amid a USD 13.5 million offering, a Nasdaq hearing set for December 3, 2026 and a customer base of 150,000 that has not stopped large losses.
Microvast Holdings (NASDAQ:MVST): Off 49.17% Pre-Market on Third-Quarter Results and Going Concern Doubt
Microvast Holdings (NASDAQ:MVST) was indicated at USD 0.3139 before the open, a fall of 49.17% against a calculated prior close of USD 0.6175. The release covering the quarter ended September 30, 2026 reported revenue down 62.8% to USD 45.8 million from USD 123.3 million, a gross Margin of 5.2% against 37.6%, and a net loss of USD 76.8 million. Adjusted EBITDA came in at negative USD 60.8 million, with a USD 9.3 million inventory write-down and USD 35.7 million of asset impairments weighing on results. On 384.5 million shares, calculated Market Value drops from about USD 237.5 million to about USD 120.7 million. Total Debt of USD 177.0 million sits against cash and restricted cash of USD 124.4 million, and the release stated that substantial doubt remains unresolved. For general context, a going concern warning makes lenders cautious. Dilution and a Reversal at the open are the hazards for Microvast Holdings (NASDAQ:MVST).
Karyopharm Therapeutics (NASDAQ:KPTI): Down 22.25% Pre-Market Over Chapter 11 and a Nasdaq Delisting Notice
Karyopharm Therapeutics (NASDAQ:KPTI) was indicated at USD 0.0311 before the open, 22.25% under a calculated prior close of USD 0.0400. The driver is the Bankruptcy process rather than fresh news from Tuesday. The company filed for Chapter 11 on November 2, 2026, backed by a USD 55 million bankruptcy loan, and Ayrmid is leading the bidding in a court-supervised sale expected to close in early 2027. Nasdaq issued a delisting notice on November 4, 2026, trading is paused from November 11, 2026, and OTC quotes are expected under KPTIQ. The company says neither its common stock nor its preferred stock will receive a payment under the plan. Shares dropped 83% to USD 0.11 on November 2. Data dated October 22 showed 22.68 million shares and short interest of 26.70% of shares, and implied market value at the pre-market price is roughly USD 0.7 million (calculated). For Karyopharm Therapeutics (NASDAQ:KPTI), a complete loss for Equity holders is the core danger.
Vivakor (NASDAQ:VIVK): Off 19.4% Before the Open, No Trigger Identified
Vivakor (NASDAQ:VIVK) was indicated at USD 0.3057 before the open, 19.4% below a calculated prior close of USD 0.3793. Published coverage does not link the decline to any single event. The closest dated item is a November 9, 2026 release reporting that four convertible notes with roughly USD 15.2 million of original Face Value were retired, the last of them through conversion on November 6. The number of shares issued was not disclosed, so dilution cannot be measured. For general context, conversions add shares to the float and can weigh on the price after a reverse split, and Vivakor announced a 1-for-15 reverse split on September 30, 2026. An October 23 quote of USD 1.44 and a market value of USD 785.63 thousand do not reconcile with the current indicated price, so a live quote should be checked. Trailing revenue was USD 89.55 million with a net loss of USD 103.26 million, and thin trading is a risk for Vivakor (NASDAQ:VIVK).
Flux Power (NASDAQ:FLUX): Down 15.9% Pre-Market, No Catalyst After Weak Results
Flux Power (NASDAQ:FLUX) was indicated at USD 0.3035 before the open, 15.9% under a calculated prior close of USD 0.3610. Nothing dated November 9 or November 10, 2026 explains the drop, so readers should weigh it against fiscal first-quarter results released on November 3, when revenue fell 48.7% to USD 6.758 million and the net loss reached USD 3.17 million. Cash was USD 409,000 while USD 6.285 million was drawn on the Credit line, equity was a Deficit of USD 431,000, and the company flagged going-concern and Nasdaq compliance risks. Second-quarter revenue guidance sits between USD 7 million and USD 8 million. With 21.62 million shares, the pre-market price implies market value of about USD 6.56 million (calculated), and the 52-week low listed on October 23 was USD 0.3900. Equity raises at these prices would dilute holders of Flux Power (NASDAQ:FLUX), and results are estimated for around November 12.
Parabolic Technologies (NASDAQ:PARA): Down 14.74% Pre-Market, No Trigger Found for Tuesday
Parabolic Technologies (NASDAQ:PARA) was indicated at USD 0.0746 before the open, 14.74% below a calculated prior close of USD 0.0875. No single trigger for Tuesday has been confirmed. The weakness appears tied to financing and listing pressure: a prospectus dated November 4, 2026 describes a USD 13.5 million offering of up to 4,963,235 units, and Nasdaq flagged a bid-price deficiency on October 27, 2026, with a hearing set for December 3. The last reported sale in the prospectus was USD 0.319, so the share price has slipped about 76.6% since then (calculated). Class A shares totalled 2,072,632 before the offering and 7,035,867 after it, and market value at the pre-market price is about USD 0.15 million (calculated). Reverse splits total 1-for-2,000, and the 2025 Annual Report includes going concern doubt. Dilution and delisting are the hazards for Parabolic Technologies (NASDAQ:PARA).
Where Things Stand
The biggest sub-USD 1.00 pre-market faller on Tuesday is Microvast Holdings at 49.17%, followed by four names that dropped between 14.74% and 22.25%. They share a price under USD 1.00 and Balance Sheet strain, whether from results, bankruptcy, conversions or an offering. Thin pre-market trades can rebound at the open because a few trades set the quote and spreads are wide. Only two of the five carry a dated catalyst in published coverage, and none of the quotes amounts to a confirmed trend. This list uses a pre-market data snapshot from November 10, 2026.






Please wait processing your request...